Tele: 561.316.3330
Breaking Medical Device News

Saturday, October 16, 2021
HomeEXECUTIVESJim O’Connor Named General Counsel and Senior Vice President, Strategic Development Announces...

Jim O’Connor Named General Counsel and Senior Vice President, Strategic Development Announces Renovia

Today Renovia announced the immediate appointment of  Jim O’Connor as General Counsel & Senior Vice President, Strategic Development.

Mr. O’Connor joined Renovia as General Counsel in February 2018 and since then has led the company’s legal, compliance, quality and regulatory functions. In his new role, Mr. O’Connor’s responsibilities will expand to include corporate business development, manufacturing, program management and overseeing Renovia’s finance team. He will also assist in identifying and implementing programs to improve organizational efficiency and execution.

“Jim has shown remarkable judgment and versatility, and has become a key cross-functional leader,” said Marc Beer, Co-Founder, Chairman and Chief Executive Officer of Renovia. “In his Strategic Development role, Jim will partner with the entire Renovia team to develop and implement strategies to maximize return on investments across our technology portfolio. As Renovia continues its growth and prepares for commercial launch of our next-generation digital therapeutics, he will also help drive potential business development and partnership opportunities.”

“I am so fortunate to work with the outstanding, mission-driven teams across Renovia and genuinely honored to take on this broader leadership role,” stated Mr. O’Connor. “I look forward to working closely with Marc and everyone at Renovia as we leverage our pipeline of digital therapeutic and diagnostic devices to help create a new standard of care in women’s health.”

Prior to joining Renovia, Mr. O’Connor worked for 12 years at United Technologies Corp. (UTC), a Fortune 100 company, in legal and business roles of increasing responsibility. Mr. O’Connor began his legal career at Testa, Hurwitz & Thibeault, where his practice focused on securities law, mergers and acquisitions and licensing transactions for private and publicly traded technology companies. Mr. O’Connor received his Bachelor of Arts from Boston College and his Juris Doctor from Cornell Law School in 1999

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy